Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$4.7 - $7.22 $75,707 - $116,299
-16,108 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$5.62 - $12.37 $1,124 - $2,474
200 Added 1.26%
16,108 $96,000
Q4 2021

Feb 11, 2022

BUY
$10.65 - $18.61 $21,853 - $38,187
2,052 Added 14.81%
15,908 $194,000
Q3 2021

Nov 12, 2021

BUY
$14.65 - $26.07 $202,990 - $361,225
13,856 New
13,856 $229,000

Others Institutions Holding CVRX

About CVRx, Inc.


  • Ticker CVRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,576,200
  • Market Cap $286M
  • Description
  • CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...
More about CVRX
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.